HEB - Hemispherx Biopharma, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts1111
Avg. Estimate-0.07-0.07-0.26-0.26
Low Estimate-0.07-0.07-0.26-0.26
High Estimate-0.07-0.07-0.26-0.26
Year Ago EPSN/AN/AN/A-0.26
Revenue EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts1111
Avg. Estimate100k70k230k380k
Low Estimate100k70k230k380k
High Estimate100k70k230k380k
Year Ago SalesN/AN/AN/A230k
Sales Growth (year/est)N/AN/AN/A65.20%
Earnings HistoryInvalid DateInvalid DateInvalid Date9/29/2018
EPS Est.N/AN/AN/A-0.06
EPS ActualN/AN/AN/A-0.07
DifferenceN/AN/AN/A-0.01
Surprise %N/AN/AN/A-16.70%
EPS TrendCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Current Estimate-0.07-0.07-0.26-0.26
7 Days Ago-0.07-0.07-0.26-0.26
30 Days Ago-0.07-0.07-0.26-0.26
60 Days Ago-0.07-0.07-0.26-0.26
90 Days Ago-0.07-0.07-0.26-0.26
EPS RevisionsCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesHEBIndustrySectorS&P 500
Current Qtr.N/AN/AN/A-0.01
Next Qtr.N/AN/AN/A0.05
Current YearN/AN/AN/A0.05
Next YearN/AN/AN/A0.11
Next 5 Years (per annum)25.00%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A